Through-Container Pharmaceutical Sensing System Development

The contract aims to develop advanced sensing systems capable of non-contact, non-destructive analysis of pharmaceutical products while still sealed in their packaging, leveraging Raman spectroscopy, terahertz imaging, and X-ray technologies to ensure product integrity, authenticity, and quality without physical interaction. The project requires the design and prototyping of integrated sensing platforms that can penetrate various container materials and accurately identify active pharmaceutical ingredients, detect counterfeits, and verify dosage forms through packaging, supporting regulatory compliance and supply chain security in the pharmaceutical industry. This subcontract is issued by the Advanced Research Projects Agency for Health under the Department of Health and Human Services, with a performance location in Washington D.C. 20005, and is categorized under NAICS code 334510 for medical and diagnostic laboratory instrument manufacturing. All proposals must be submitted by August 20, 2026, with the opportunity posted on July 28, 2026, targeting organizations capable of interdisciplinary innovation in sensing technologies with proven expertise in biomedical applications and industrial-grade prototyping under stringent pharmaceutical standards.